← SELECT MEDICAL HOLDINGS CORP SEM
Market Price
$16.52
Market Cap
$2.05B
P/E Ratio
14.24
Revenue (FY 2025)
↑5.1% YoY
$5.45B
3-Yr CAGR: -4.9%
Net Income
↓-31.7% YoY
$146.22M
Net Margin: 2.7%
Free Cash Flow
↓-60.3% YoY
$117.24M
FCF Yield: 5.72%
EPS (Diluted)
↓-30.1% YoY
$1.16
Basic: $1.16
Return on Equity
Efficiency
8.6%
ROA: 14.3%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (SEM)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $4,217.5M | — | $4,047.4M | $115.4M | — | $0.87 | — | $346.6M | $185.0M | — |
| FY 2017 | $4,365.2M | +3.5% | $4,210.5M | $177.2M | +53.5% | $1.33 | +52.9% | $238.1M | $4.9M | -97.4% |
| FY 2018 | $5,081.3M | +16.4% | $4,882.8M | $137.8M | -22.2% | $1.02 | -23.3% | $494.2M | $326.9M | +6,588.1% |
| FY 2019 | $5,453.9M | +7.3% | $5,253.4M | $148.4M | +7.7% | $1.10 | +7.8% | $445.2M | $288.1M | -11.9% |
| FY 2020 | $5,531.7M | +1.4% | $5,378.7M | $259.0M | +74.5% | $1.93 | +75.5% | $1,028.1M | $881.6M | +206.1% |
| FY 2021 | $6,204.5M | +12.2% | $6,068.5M | $402.2M | +55.3% | $2.98 | +54.4% | $401.2M | $220.7M | -75.0% |
| FY 2022 | $6,333.5M | +2.1% | $6,164.4M | $159.0M | -60.5% | $1.23 | -58.7% | $284.8M | $94.5M | -57.2% |
| FY 2023 | $6,664.1M | +5.2% | $6,465.4M | $243.5M | +53.1% | $1.91 | +55.3% | $582.1M | $352.9M | +273.6% |
| FY 2024 | $5,187.1M | -22.2% | $5,058.5M | $214.0M | -12.1% | $1.66 | -13.1% | $517.9M | $295.7M | -16.2% |
| FY 2025 | $5,452.8M | +5.1% | $5,334.9M | $146.2M | -31.7% | $1.16 | -30.1% | $346.5M | $117.2M | -60.3% |
Valuation
Market Price
$16.52
Market Cap
$2.05B
Enterprise Value
N/A
P/E Ratio
14.24
P/B Ratio
1.20
FCF Yield
5.72%
Dividend Yield
1.51%
Shares Outstanding
Profitability & Margins
Gross Margin
97.84%
Operating Margin
6.17%
Net Margin
2.68%
Return on Equity (ROE)
8.57%
Return on Assets (ROA)
14.26%
Asset Turnover
5.32x
Revenue 3-Yr CAGR
-4.87%
Financial Health & Liquidity
Current Ratio
1.04
Cash Ratio
0.03
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$26.52M
Total Debt
N/A
Book Value / Share
$13.75
Cash Flow Efficiency
Operating Cash Flow
$346.47M
Capital Expenditures (CapEx)
$229.22M
Free Cash Flow
$117.24M
OCF / Revenue
6.35%
FCF / Revenue
2.15%
FCF 3-Yr CAGR
7.47%
Per Share Metrics
EPS (Diluted)
$1.16
EPS (Basic)
$1.16
Dividends / Share
$0.25
Book Value / Share
$13.75
EPS YoY Growth
-30.12%
Balance Sheet (FY 2025)
Total Assets
$1.03B
Total Liabilities
$984.49M
Stockholders' Equity
$1.71B
Current Assets
$1.03B
Current Liabilities
$984.49M